Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer.

Zhu J, Sharma DB, Gray SW, Chen AB, Weeks JC, Schrag D.

JAMA. 2012 Apr 18;307(15):1593-601. doi: 10.1001/jama.2012.454.

PMID:
22511687
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer.

de Gramont A, Van Cutsem E.

Oncology. 2005;69 Suppl 3:46-56. Epub 2005 Nov 21. Review.

PMID:
16301835
[PubMed - indexed for MEDLINE]
3.

Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer.

Okamoto I, Moriyama E, Fujii S, Kishi H, Nomura M, Goto E, Kiyofuji C, Imamura F, Mori T, Matsumoto M.

Jpn J Clin Oncol. 2005 Apr;35(4):188-94. Review.

PMID:
15845567
[PubMed - indexed for MEDLINE]
Free Article
4.

Bevacizumab in non-small cell lung cancer.

Di Costanzo F, Mazzoni F, Micol Mela M, Antonuzzo L, Checcacci D, Saggese M, Di Costanzo F.

Drugs. 2008;68(6):737-46. Review.

PMID:
18416583
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk